目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 70)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 RESEARCH LIMITATIONS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 76)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, SOFTWARE & SERVICE, AND END USER)
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 8 MARKET: CAGR PROJECTIONS, 2023-2028
FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF ECONOMIC RECESSION ON MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024-2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019-2027 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY (Page No. - 88)
FIGURE 11 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MARKET, BY REAGENT, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY SOFTWARE & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 15 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MARKET

4 PREMIUM INSIGHTS (Page No. - 93)
4.1 OVERVIEW OF PROTEOMICS MARKET
FIGURE 17 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET
4.2 NORTH AMERICA: MARKET SHARE, BY APPLICATION AND COUNTRY (2022)
FIGURE 18 CLINICAL DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
4.3 ELECTROPHORESIS MARKET SHARE, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 19 GEL ELECTROPHORESIS TO DOMINATE MARKET IN 2028
4.4 MARKET SHARE, BY END USER (2022)
FIGURE 20 PHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN MARKET DURING STUDY PERIOD

5 MARKET OVERVIEW (Page No. - 97)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for personalized medicines for clinical practices
FIGURE 23 PERSONALIZED MEDICINES APPROVED BY FDA, 2015-2022
5.2.1.2 Rising incidences of chronic diseases among geriatric population
5.2.1.3 Increased investments in research and greater adoption of proteomics in drug discovery
FIGURE 24 GLOBAL SPENDING ON PHARMACEUTICAL R&D, 2015-2028 (USD BILLION)
5.2.1.4 Technological advancements in proteomics
5.2.2 RESTRAINTS
5.2.2.1 High costs of proteomics instruments and technologies
5.2.2.2 Lack of standardization in proteomics workflow among research groups
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities for proteomics research in emerging countries
5.2.3.2 Growing prominence of nano proteomics in biological processes
5.2.4 CHALLENGES
5.2.4.1 Low biomarker discovery to approval ratio in proteomics research
5.2.4.2 Lack of data management/handling in proteomics research
5.3 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: MANUFACTURING AND DISTRIBUTION PHASES PROVIDE MAXIMUM VALUE
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 26 MARKET: SUPPLY CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 27 ECOSYSTEM ANALYSIS: MARKET
TABLE 5 MARKET: ROLE IN ECOSYSTEM
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 PATENT ANALYSIS
5.8 PRICING ANALYSIS
TABLE 7 AVERAGE SELLING PRICE OF PROTEOMICS PRODUCTS (2022)
TABLE 8 PERKINELMER: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES
TABLE 9 MERCK: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES
5.9 TECHNOLOGY ANALYSIS
TABLE 10 COMPARISON OF MODERN PROTEOMICS ANALYSIS METHODS
TABLE 11 COMMONLY USED BIOINFORMATICS TOOLS IN PROTEOMICS
TABLE 12 TECHNOLOGIES LAUNCHED RECENTLY IN PROTEOMICS
5.10 REGULATORY ANALYSIS
5.10.1 REGULATIONS FOR PRODUCTS DEVELOPED USING PROTEOMICS TECHNIQUES
TABLE 13 KEY REGULATORY GUIDELINES FOR PROTEOMICS PRODUCTS
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 KEY CONFERENCES AND EVENTS IN 2023
TABLE 17 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS
5.12.2 BUYING CRITERIA
FIGURE 29 KEY BUYING CRITERIA FOR END USERS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14 TRADE ANALYSIS
5.14.1 TRADE ANALYSIS FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS
TABLE 19 IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2017-2021 (USD MILLION)
5.14.2 TRADE ANALYSIS FOR DIAGNOSTICS AND LABORATORY REAGENTS
TABLE 20 IMPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017-2021 (USD MILLION)
TABLE 21 EXPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017-2021 (TONS)
5.14.3 TRADE ANALYSIS FOR IMMUNOASSAYS
TABLE 22 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2017-2021 (USD MILLION)

6 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY (Page No. - 122)
6.1 INTRODUCTION
6.1.1 PRICING ANALYSIS
TABLE 23 AVERAGE SELLING PRICE OF PRODUCTS AND SERVICES, 2022 (USD)
TABLE 24 MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
6.2 SPECTROSCOPY
TABLE 25 MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 26 MARKET FOR SPECTROSCOPY, BY REGION, 2021-2028 (USD MILLION)
TABLE 27 NORTH AMERICA: MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 28 EUROPE: MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC: MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 30 LATIN AMERICA: MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.1 MASS SPECTROSCOPY
6.2.1.1 High specificity of mass spectroscopy to boost market
TABLE 31 MASS SPECTROSCOPY MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 32 NORTH AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 33 EUROPE: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 34 ASIA PACIFIC: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 35 LATIN AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.2 NMR SPECTROSCOPY
6.2.2.1 NMR experiments to evaluate physical, chemical, electronic, and structural information of proteins
TABLE 36 NMR SPECTROSCOPY MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 37 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 38 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 39 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 40 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.3 CD SPECTROSCOPY
6.2.3.1 CD spectroscopy to examine changes in secondary structures of protein in response to environmental conditions
TABLE 41 CD SPECTROSCOPY MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 42 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 43 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 44 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 45 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3 CHROMATOGRAPHY
TABLE 46 MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 47 MARKET FOR CHROMATOGRAPHY, BY REGION, 2021-2028 (USD MILLION)
TABLE 48 NORTH AMERICA: MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 49 EUROPE: MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 51 LATIN AMERICA: MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.1 HPLC
6.3.1.1 Growing biopharmaceutical industry and increasing investments in life science research
TABLE 52 HPLC MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 53 NORTH AMERICA: HPLC MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 54 EUROPE: HPLC MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 55 ASIA PACIFIC: HPLC MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 56 LATIN AMERICA: HPLC MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.2 ION CHROMATOGRAPHY
6.3.2.1 Ion chromatography to be most significant chromatographic technique for separation and purification of proteins
TABLE 57 ION CHROMATOGRAPHY MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 58 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 59 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 60 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 61 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.3 AFFINITY CHROMATOGRAPHY
6.3.3.1 Affinity chromatography to quantify protein expression using isotope-coded affinity tags
TABLE 62 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 63 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 64 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 65 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 66 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
6.3.4.1 Supercritical fluid chromatography to separate complex protein mixtures with high efficiency and speed
TABLE 67 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 68 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 69 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 70 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 71 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.4 ELECTROPHORESIS
TABLE 72 MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 73 MARKET FOR ELECTROPHORESIS, BY REGION, 2021-2028 (USD MILLION)
TABLE 74 NORTH AMERICA: MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 75 EUROPE: MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 76 ASIA PACIFIC: MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 77 LATIN AMERICA: MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021-2028 (USD MILLION)
6.4.1 GEL ELECTROPHORESIS
6.4.1.1 Increasing demand for gel electrophoresis in proteomics research and personalized medicine
TABLE 78 GEL ELECTROPHORESIS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 79 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 80 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 81 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 82 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.4.2 CAPILLARY ELECTROPHORESIS
6.4.2.1 Rise in applications of capillary electrophoresis in therapeutics and drug discovery
TABLE 83 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 84 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 85 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 86 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 87 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.5 PROTEIN MICROARRAYS
TABLE 88 MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 89 MARKET FOR PROTEIN MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 91 EUROPE: MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 92 ASIA PACIFIC: MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 93 LATIN AMERICA: MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
6.5.1 BIOCHIPS
TABLE 94 BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 95 BIOCHIPS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 96 NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 97 EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 98 ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 99 LATIN AMERICA: BIOCHIPS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.5.1.1 Lab-on-chips
6.5.1.1.1 Rising applications of lab-on-chips in microfabrication and nanotechnology development
TABLE 100 LAB-ON-CHIPS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 101 NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 102 EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 103 ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 104 LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.5.1.2 Protein chips
6.5.1.2.1 Competitive advantage over conventional protein analysis tools
TABLE 105 PROTEIN CHIPS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 106 NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 107 EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 108 ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 109 LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.5.2 MICROARRAY INSTRUMENTS
TABLE 110 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 111 MICROARRAY INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 112 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 113 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 115 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.5.2.1 Integrated systems
6.5.2.1.1 Integrated systems to enable high-throughput and reproducible analysis of large numbers of proteins
TABLE 116 INTEGRATED SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 117 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 118 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 119 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 120 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.5.2.2 Microarray scanners
6.5.2.2.1 Microarray scanners to provide high-quality analysis and cost efficiency
TABLE 121 MICROARRAY SCANNERS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 122 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 123 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 124 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 125 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.5.2.3 Arrayers
6.5.2.3.1 Technological advancements to make microarray spotters ideal for large-scale arraying projects
TABLE 126 ARRAYERS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 127 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 128 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 130 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.6 X-RAY CRYSTALLOGRAPHY
6.6.1 INCREASED NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES WITH X-RAY CRYSTALLOGRAPHY TO AID MARKET
TABLE 131 MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION, 2021-2028 (USD MILLION)
TABLE 132 NORTH AMERICA: MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 133 EUROPE: MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 135 LATIN AMERICA: MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021-2028 (USD MILLION)
6.7 SURFACE PLASMON RESONANCE
6.7.1 ABILITY TO MEASURE BINDING AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET
TABLE 136 MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2021-2028 (USD MILLION)
TABLE 137 NORTH AMERICA: MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 138 EUROPE: MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 139 ASIA PACIFIC: MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 140 LATIN AMERICA: MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021-2028 (USD MILLION)
6.8 PROTEIN FRACTIONATION
6.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF THOUSANDS OF PROTEINS IN COMPLEX MIXTURES
TABLE 141 MARKET FOR PROTEIN FRACTIONATION, BY REGION, 2021-2028 (USD MILLION)
TABLE 142 NORTH AMERICA: MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 143 EUROPE: MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 144 ASIA PACIFIC: MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 145 LATIN AMERICA: MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021-2028 (USD MILLION)
6.9 OTHER TECHNOLOGIES
TABLE 146 MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 147 NORTH AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 148 EUROPE: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 149 ASIA PACIFIC: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 150 LATIN AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

7 PROTEOMICS MARKET, BY REAGENT (Page No. - 201)
7.1 INTRODUCTION
TABLE 151 MARKET, BY REAGENT, 2021-2028 (USD MILLION)
7.2 IMMUNOASSAY REAGENTS
7.2.1 IMMUNOASSAY REAGENTS TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 152 MARKET FOR IMMUNOASSAY REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 153 NORTH AMERICA: MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 154 EUROPE: MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 155 ASIA PACIFIC: MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 156 LATIN AMERICA: MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
7.3 SPECTROSCOPY REAGENTS
7.3.1 INCREASED ADOPTION OF MS-BASED APPROACHES IN PROTEOMICS TO DRIVE MARKET
TABLE 157 MARKET FOR SPECTROSCOPY REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 158 NORTH AMERICA: MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 159 EUROPE: MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 160 ASIA PACIFIC: MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 161 LATIN AMERICA: MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
7.4 CHROMATOGRAPHY REAGENTS
7.4.1 INCREASING DEMAND FOR PROTEIN PURIFICATION TO AID MARKET
TABLE 162 MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 163 NORTH AMERICA: MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 164 EUROPE: MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 165 ASIA PACIFIC: MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 166 LATIN AMERICA: MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
7.5 PROTEIN MICROARRAY REAGENTS
7.5.1 INCREASED FOCUS ON ANALYZING PROTEIN INTERACTIONS TO INCREASE USE OF PROTEIN MICROARRAY REAGENTS
TABLE 167 MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 168 NORTH AMERICA: MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 169 EUROPE: MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 170 ASIA PACIFIC: MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 171 LATIN AMERICA: MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
7.6 X-RAY CRYSTALLOGRAPHY REAGENTS
7.6.1 X-RAY CRYSTALLOGRAPHY TO BE ESSENTIAL IN PROTEIN STRUCTURE DETERMINATION
TABLE 172 MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 173 NORTH AMERICA: MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 174 EUROPE: MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 175 ASIA PACIFIC: MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 176 LATIN AMERICA: MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
7.7 ELECTROPHORESIS REAGENTS
7.7.1 INCREASING DEMAND FOR 2D ELECTROPHORESIS TO PROPEL MARKET
TABLE 177 MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 178 NORTH AMERICA: MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 179 EUROPE: MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 180 ASIA PACIFIC: MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 181 LATIN AMERICA: MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
7.8 PROTEIN FRACTIONATION REAGENTS
7.8.1 INCREASING NEED FOR PROTEIN SEPARATION FROM COMPLEX MIXTURES TO AUGMENT MARKET
TABLE 182 MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 183 NORTH AMERICA: MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 184 EUROPE: MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 185 ASIA PACIFIC: MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 186 LATIN AMERICA: MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
7.9 OTHER REAGENTS
TABLE 187 MARKET FOR OTHER REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 188 NORTH AMERICA: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 189 EUROPE: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 190 ASIA PACIFIC: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 191 LATIN AMERICA: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)

8 PROTEOMICS MARKET, BY SERVICE & SOFTWARE (Page No. - 228)
8.1 INTRODUCTION
TABLE 192 MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
8.2 CORE PROTEOMICS SERVICES
TABLE 193 MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 194 MARKET FOR CORE PROTEOMICS SERVICES, BY REGION, 2021-2028 (USD MILLION)
TABLE 195 NORTH AMERICA: MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 196 EUROPE: MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 197 ASIA PACIFIC: MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 198 LATIN AMERICA: MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
8.2.1 PROTEIN IDENTIFICATION SERVICES
8.2.1.1 Rising demand for molecular weight analysis to boost market growth
TABLE 199 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 200 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 201 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 202 ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 203 LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
8.2.2 PROTEIN CHARACTERIZATION SERVICES
8.2.2.1 Increased focus on study of complex protein structure, drug development, and PTMs to drive segment
TABLE 204 PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 205 NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021-2028 (USD MILLION)
TABLE 206 EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021-2028 (USD MILLION)
TABLE 207 ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 208 LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021-2028 (USD MILLION)
8.2.3 QUANTITATIVE PROTEOMICS SERVICES
8.2.3.1 Quantitative proteomics to be critical for understanding protein expression and modifications
TABLE 209 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 210 NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 211 EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 212 ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 213 LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
8.2.4 PROTEIN PURIFICATION SERVICES
8.2.4.1 Protein purification services to improve overall proteome analysis
TABLE 214 PROTEIN PURIFICATION SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 215 NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 216 EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 217 ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 218 LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
8.2.5 PROTEIN SEPARATION SERVICES
8.2.5.1 Protein separation services to characterize large-sized proteomes of different sizes
TABLE 219 PROTEIN SEPARATION SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 220 NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 221 EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 222 ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 223 LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
8.2.6 PROTEIN SEQUENCING SERVICES
8.2.6.1 Identification and characterization of post-translational modifications to determine characterizations of proteins
TABLE 224 PROTEIN SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 225 NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 226 EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 227 ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 228 LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
8.2.7 CUSTOM ASSAY SERVICES
8.2.7.1 Custom assays to improve validation or consistency of protein analysis procedures
TABLE 229 CUSTOM ASSAY SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 230 NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 231 EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 232 ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 233 LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
8.3 BIOINFORMATICS SOFTWARE & SERVICES
TABLE 234 MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
8.3.1 BIOINFORMATICS SERVICES
8.3.1.1 Bioinformatics services to dominate market during study period
TABLE 235 BIOINFORMATICS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 236 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 237 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 238 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 239 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION
8.3.2 BIOINFORMATICS TOOLS
8.3.2.1 Increased need for data management to drive segment
TABLE 240 BIOINFORMATICS TOOLS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 241 NORTH AMERICA: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 242 EUROPE: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 243 ASIA PACIFIC: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 244 LATIN AMERICA: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
8.3.3 BIOINFORMATICS DATABASES
8.3.3.1 Growing need to store proteomics data and integrate other omics databases to fuel market
TABLE 245 BIOINFORMATICS DATABASES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 246 NORTH AMERICA: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 247 EUROPE: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 248 ASIA PACIFIC: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 249 LATIN AMERICA: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

9 PROTEOMICS MARKET, BY APPLICATION (Page No. - 266)
9.1 INTRODUCTION
TABLE 250 MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
9.2 CLINICAL DIAGNOSTICS
TABLE 251 MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 252 MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021-2028 (USD MILLION)
TABLE 253 NORTH AMERICA: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 254 EUROPE: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 255 ASIA PACIFIC: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 256 LATIN AMERICA: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.1 CANCER
9.2.1.1 Increasing investments in cancer research to drive market
TABLE 257 CANCER MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 258 NORTH AMERICA: CANCER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 259 EUROPE: CANCER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 260 ASIA PACIFIC: CANCER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 261 LATIN AMERICA: CANCER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.2 INFECTIOUS DISEASES
9.2.2.1 Growing prevalence of infectious diseases in emerging economices to propel market
TABLE 262 INFECTIOUS DISEASES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 263 NORTH AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 264 EUROPE: INFECTIOUS DISEASES MARKET, BY COUNTRY 2021-2028 (USD MILLION)
TABLE 265 ASIA PACIFIC: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 266 LATIN AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.3 DIABETES
9.2.3.1 Rising investments in diabetes research to drive market growth
TABLE 267 DIABETES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 268 NORTH AMERICA: DIABETES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 269 EUROPE: DIABETES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 270 ASIA PACIFIC: DIABETES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 271 LATIN AMERICA: DIABETES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.4 NEUROLOGICAL DISORDERS
9.2.4.1 Increasing clinical trials and research in neurological disorders to fuel market
TABLE 272 NEUROLOGICAL DISORDERS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 273 NORTH AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 274 EUROPE: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 275 ASIA PACIFIC: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 276 LATIN AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.5 AUTOIMMUNE DISEASES
9.2.5.1 Increasing demand for proteomics in diagnosis of autoimmune diseases to boost market
TABLE 277 AUTOIMMUNE DISEASES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 278 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 279 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 280 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 281 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.6 CARDIOVASCULAR DISEASES
9.2.6.1 High burden of cardiovascular diseases globally to increase development of more reliable proteomics tools
TABLE 282 CARDIOVASCULAR DISEASES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 283 NORTH AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 284 EUROPE: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 285 ASIA PACIFIC: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 286 LATIN AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS
TABLE 287 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 288 NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 289 EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 290 ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 291 LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.3 DRUG DISCOVERY & DEVELOPMENT
TABLE 292 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 293 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
TABLE 294 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 295 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 296 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 297 LATIN AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
9.3.1 TARGET DISCOVERY
9.3.1.1 Increasing demand for personalized medicine to support market
TABLE 298 TARGET DISCOVERY MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 299 NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 300 EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 301 ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 302 LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.3.2 LEAD IDENTIFICATION
9.3.2.1 Lead identification to be most revenue-generating process among drug discovery & development processes
TABLE 303 LEAD IDENTIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 304 NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 305 EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 306 ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 307 LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.3.3 LEAD OPTIMIZATION
9.3.3.1 Lead optimization to require state-of-the-art informatics systems for transparent presentation and analysis
TABLE 308 LEAD OPTIMIZATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 309 NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 310 EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 311 ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 312 LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.3.4 PRECLINICAL STUDIES
9.3.4.1 Preclinical studies to facilitate transparent presentation and analysis of latest data for rapid reprioritization of synthetic targets
TABLE 313 PRECLINICAL STUDIES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 314 NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 315 EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 316 ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 317 LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
9.4 OTHER APPLICATIONS
TABLE 318 MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 319 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 320 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 321 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 322 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

10 PROTEOMICS MARKET, BY END USER (Page No. - 312)
10.1 INTRODUCTION
TABLE 323 MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2 HOSPITALS
10.2.1 RISING ADOPTION OF PROTEOMICS FOR DISEASE DIAGNOSIS TO DRIVE MARKET
TABLE 324 MARKET FOR HOSPITALS, BY REGION, 2021-2028 (USD MILLION)
TABLE 325 NORTH AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 326 EUROPE: MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 327 ASIA PACIFIC: MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 328 LATIN AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
10.3 CLINICAL LABORATORIES
10.3.1 INCREASING OUTSOURCING OF DIAGNOSTICS TESTS BY HOSPITALS TO SUPPORT SEGMENT
TABLE 329 MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 330 NORTH AMERICA: MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 331 EUROPE: MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 332 ASIA PACIFIC: MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 333 LATIN AMERICA: MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.4.1 RISING FOCUS ON DRUG DISCOVERY IN BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET
TABLE 334 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 335 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 336 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 337 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 338 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
10.5 ACADEMIC RESEARCH LABORATORIES
10.5.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINES TO AUGMENT MARKET
TABLE 339 MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 340 NORTH AMERICA: MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 341 EUROPE: MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 342 ASIA PACIFIC: MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 343 LATIN AMERICA: MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
10.6 OTHER END USERS
TABLE 344 MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
TABLE 345 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 346 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 347 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 348 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

11 PROTEOMICS MARKET, BY REGION (Page No. - 330)
11.1 INTRODUCTION
TABLE 349 MARKET, BY REGION, 2021-2028 (USD MILLION)
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
FIGURE 30 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT
TABLE 350 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 351 NORTH AMERICA: MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 352 NORTH AMERICA: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 353 NORTH AMERICA: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 354 NORTH AMERICA: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 355 NORTH AMERICA: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 356 NORTH AMERICA: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 357 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 358 NORTH AMERICA: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 359 NORTH AMERICA: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 360 NORTH AMERICA: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 361 NORTH AMERICA: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 362 NORTH AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 363 NORTH AMERICA: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 364 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 365 NORTH AMERICA: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.2.2 US
11.2.2.1 US to dominate North American proteomics market during forecast period
TABLE 366 US: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 367 US: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 368 US: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 369 US: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 370 US: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 371 US: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 372 US: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 373 US: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 374 US: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 375 US: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 376 US: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021-2028 (USD MILLION)
TABLE 377 US: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 378 US: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 379 US: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 380 US: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Strong infrastructure and increased availability of funding for biomedical research to support market
TABLE 381 CANADA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 382 CANADA: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 383 CANADA: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 384 CANADA: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 385 CANADA: MARKET FOR PROTEIN MICROARRAYS, 2021-2028 (USD MILLION)
TABLE 386 CANADA: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 387 CANADA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 388 CANADA: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 389 CANADA: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 390 CANADA: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 391 CANADA: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021-2028 (USD MILLION)
TABLE 392 CANADA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 393 CANADA: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 394 CANADA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 395 CANADA: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: IMPACT OF RECESSION
TABLE 396 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 397 EUROPE: MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 398 EUROPE: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 399 EUROPE: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 400 EUROPE: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 401 EUROPE: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 402 EUROPE: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 403 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 404 EUROPE: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 405 EUROPE: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 406 EUROPE: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 407 EUROPE: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 408 EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 409 EUROPE: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 410 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 411 EUROPE: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Germany to be largest market for proteomics in European region during forecast period
TABLE 412 GERMANY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 413 GERMANY: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 414 GERMANY: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 415 GERMANY: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 416 GERMANY: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 417 GERMANY: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 418 GERMANY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 419 GERMANY: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 420 GERMANY: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 421 GERMANY: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 422 GERMANY: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 423 GERMANY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 424 GERMANY: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 425 GERMANY: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 426 GERMANY: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.3 UK
11.3.3.1 High prevalence of cancer and growth in life science industry to fuel market
TABLE 427 UK: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY 2021-2028 (USD MILLION)
TABLE 428 UK: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 429 UK: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 430 UK: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 431 UK: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 432 UK: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 433 UK: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 434 UK: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 435 UK: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 436 UK: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 437 UK: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 438 UK: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 439 UK: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 440 UK: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 441 UK: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Development of new proteomics-based diagnostic tools and investments in life science R&D to drive market
TABLE 442 FRANCE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 443 FRANCE: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 444 FRANCE: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 445 FRANCE: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 446 FRANCE: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 447 FRANCE: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 448 FRANCE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 449 FRANCE: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 450 FRANCE: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 451 FRANCE: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 452 FRANCE: MARKET, FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 453 FRANCE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 454 FRANCE: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 455 FRANCE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 456 FRANCE: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.5 SWITZERLAND
11.3.5.1 Well-established pharmaceutical & biotechnology industry and increased investments in life science R&D infrastructure to augment market
TABLE 457 SWITZERLAND: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 458 SWITZERLAND: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 459 SWITZERLAND: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 460 SWITZERLAND: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 461 SWITZERLAND: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 462 SWITZERLAND: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 463 SWITZERLAND: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 464 SWITZERLAND: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 465 SWITZERLAND: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 466 SWITZERLAND: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 467 SWITZERLAND: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 468 SWITZERLAND: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 469 SWITZERLAND: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 470 SWITZERLAND: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 471 SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.6 ITALY
11.3.6.1 Increase in federal grants and private funding programs to support projects on translational research
TABLE 472 ITALY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 473 ITALY: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 474 ITALY: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 475 ITALY: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 476 ITALY: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 477 ITALY: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 478 ITALY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 479 ITALY: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 480 ITALY: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 481 ITALY: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 482 ITALY: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 483 ITALY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 484 ITALY: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 485 ITALY: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 486 ITALY: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.7 SPAIN
11.3.7.1 Well-established network of research centers, universities, and hospitals to aid proteomics research
TABLE 487 SPAIN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 488 SPAIN: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 489 SPAIN: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 490 SPAIN: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 491 SPAIN: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 492 SPAIN: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 493 SPAIN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 494 SPAIN: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 495 SPAIN: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 496 SPAIN: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 497 SPAIN: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 498 SPAIN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 499 SPAIN: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 500 SPAIN: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 501 SPAIN: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.8 REST OF EUROPE
TABLE 502 REST OF EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 503 REST OF EUROPE: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 504 REST OF EUROPE: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 505 REST OF EUROPE: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 506 REST OF EUROPE: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 507 REST OF EUROPE: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 508 REST OF EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 509 REST OF EUROPE: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 510 REST OF EUROPE: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 511 REST OF EUROPE: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 512 REST OF EUROPE: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 513 REST OF EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 514 REST OF EUROPE: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 515 REST OF EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 516 REST OF EUROPE: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
FIGURE 31 ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT
TABLE 517 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 518 ASIA PACIFIC: MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 519 ASIA PACIFIC: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 520 ASIA PACIFIC: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 521 ASIA PACIFIC: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 522 ASIA PACIFIC: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 523 ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 524 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 525 ASIA PACIFIC: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 526 ASIA PACIFIC: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 527 ASIA PACIFIC: MARKET FOR CORE PROTEOMICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 528 ASIA PACIFIC: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 529 ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 530 ASIA PACIFIC: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 531 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 532 ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Heavy investments in life science industry and establishment of proteomics research centers to drive market
TABLE 533 CHINA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 534 CHINA: MARKET FOR SPECTROSCOPY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 535 CHINA: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 536 CHINA: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 537 CHINA: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 538 CHINA: BIOCHIPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 539 CHINA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 540 CHINA: MARKET, BY REAGENT, 2021-2028 (USD MILLION)
TABLE 541 CHINA: MARKET, BY SOFTWARE & SERVICE, 2021-2028 (USD MILLION)
TABLE 542 CHINA: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 543 CHINA: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 544 CHINA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 545 CHINA: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 546 CHINA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021-2028 (USD MILLION)
TABLE 547 CHINA: PROTEOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.3 JAPAN
11.4.3.1 Increased targeted funding for precision medicine research to support market
TABLE 548 JAPA